Maximize the profitability of your ophthalmology products by capitalizing on pricing and reimbursement opportunities

New products for major ophthalmology indications have to be established in treatment pathways dominated by non-drug interventions such as laser treatment and surgery.


We have extensive experience in advising clients on how to demonstrate product value to a wide range of stakeholders, including patients, providers, and local and national payers.


Cutting-edge solutions and creative recommendations for ophthalmology reimbursement and market access


Examples of the disease areas we have worked in include:

  • diabetic macular edema
  • dry eye
  • glaucoma.

You can work with us at an early stage in the development of your ophthalmology product to establish your pricing, reimbursement, and market access strategy; or you can benefit from guidance throughout the whole process with evidence generation, evidence synthesis, and communication. If you have one-off challenges, our expert team is able to address those as well.

Request a call

Thank you for all your work and expertise in putting these policy recommendations together. I am glad we were able to obtain approval so swiftly. This is due to the quality of the comments put together with PRMA Consulting’s support. We greatly appreciate your commitment to this project.

Global Development Manager, top-10 pharmaceutical company

You have a vision; we are the consulting partner that will get you there.
We would be delighted to have a confidential conversation about your market access needs.